<?xml version="1.0" encoding="UTF-8"?>
<abstract abstract-type="author-highlights" id="abs0020">
 <title>Highlights</title>
 <p>
  <list list-type="simple" id="ulist0010">
   <list-item id="u0010">
    <label>•</label>
    <p id="p0010">The WHO has set global targets for elimination of hepatitis B by 2030</p>
   </list-item>
   <list-item id="u0015">
    <label>•</label>
    <p id="p0015">To date, global investment in hepatitis B elimination activities has been limited</p>
   </list-item>
   <list-item id="u0020">
    <label>•</label>
    <p id="p0020">We have developed a global investment framework for the elimination of hepatitis B to guide domestic and international investment</p>
   </list-item>
   <list-item id="u0025">
    <label>•</label>
    <p id="p0025">This Health Policy paper outlines evidence to support the financial returns on investment in hepatitis B elimination, identifies national and international activities to achieve hepatitis B elimination targets and identifies potential funding sources</p>
   </list-item>
   <list-item id="u0030">
    <label>•</label>
    <p id="p0030">The goal of this investment framework is to pave the way for countries to build the economic case for investment in national hepatitis B elimination programmes.</p>
   </list-item>
  </list>
 </p>
</abstract>
